Cargando…
Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity
Basic fibroblast growth factor (bFGF), which plays an important role in tumour angiogenesis and progression, provides a potential target for cancer therapy. Here we screened a phage display heptapeptide library with bFGF and identified 11 specific bFGF-binding phage clones. Two of these clones had i...
Autores principales: | Wu, Xiaoping, Yan, Qiuxia, Huang, Yadong, Huang, Huixian, Su, Zhijian, Xiao, Jian, Zeng, Yaoying, Wang, Yi, Nie, Changjun, Yang, Yongguang, Li, Xiaokun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837584/ https://www.ncbi.nlm.nih.gov/pubmed/20414975 http://dx.doi.org/10.1111/j.1582-4934.2008.00506.x |
Ejemplares similares
-
Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation
por: Wu, Xiaoping, et al.
Publicado: (2013) -
Expression and Purification of Human Keratinocyte Growth Factor 2 by Fusion with SUMO
por: Wu, Xiaoping, et al.
Publicado: (2008) -
On the use of antiangiogenetic medications for retinopathy of prematurity
por: Hård, Anna-Lena, et al.
Publicado: (2011) -
Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy
por: Ammendola, Michele, et al.
Publicado: (2014) -
Effects of Antiangiogenetic Drugs on Microcirculation and Macrocirculation in Patients with Advanced-Stage Renal Cancer
por: Dalbeni, Andrea, et al.
Publicado: (2018)